09:18:03 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-30 Kvartalsrapport 2024-Q3
2024-07-25 Kvartalsrapport 2024-Q2
2024-04-29 Ordinarie utdelning MCOV B 1.35 SEK
2024-04-26 Årsstämma 2024
2024-04-26 Kvartalsrapport 2024-Q1
2024-02-09 Bokslutskommuniké 2023
2023-11-03 Kvartalsrapport 2023-Q3
2023-07-26 Kvartalsrapport 2023-Q2
2023-04-28 Ordinarie utdelning MCOV B 1.37 SEK
2023-04-27 Kvartalsrapport 2023-Q1
2023-04-27 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-07-22 Kvartalsrapport 2022-Q2
2022-04-28 Ordinarie utdelning MCOV B 1.25 SEK
2022-04-27 Årsstämma 2022
2022-04-27 Kvartalsrapport 2022-Q1
2022-02-11 Bokslutskommuniké 2021
2021-11-03 Kvartalsrapport 2021-Q3
2021-07-23 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning MCOV B 0.71 SEK
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-29 Årsstämma 2021
2021-02-12 Bokslutskommuniké 2020
2020-11-06 Kvartalsrapport 2020-Q3
2020-07-24 Kvartalsrapport 2020-Q2
2020-05-04 Ordinarie utdelning MCOV B 0.00 SEK
2020-04-30 Kvartalsrapport 2020-Q1
2020-04-30 Årsstämma 2020
2020-02-14 Bokslutskommuniké 2019
2019-11-06 Kvartalsrapport 2019-Q3
2019-07-26 Kvartalsrapport 2019-Q2
2019-05-06 Ordinarie utdelning MCOV B 0.00 SEK
2019-05-03 Kvartalsrapport 2019-Q1
2019-05-03 Årsstämma 2019
2019-02-15 Bokslutskommuniké 2018
2018-10-26 Kvartalsrapport 2018-Q3
2018-07-27 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning MCOV B 0.00 SEK
2018-04-26 Årsstämma 2018
2018-04-26 Kvartalsrapport 2018-Q1
2018-02-09 Bokslutskommuniké 2017
2017-10-27 Kvartalsrapport 2017-Q3
2017-07-28 Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriVård & Omsorg
Medicover är verksamt inom vård- och omsorg. Affärsverksamheten är inriktad mot servicetjänster inom hälsovård samt diagnostik. Bolaget erbjuder primär- och specialiserad vård, finansieringslösningar samt laboratorietester inom patologi. Huvudmarknaden återfinns runtom den europeiska marknaden med forskningsinstitut som dominerande kundbas. Medicover grundades under 1995 och har sitt huvudkontor i Stockholm.
2019-05-10 18:20:00

The earlier announced acquisition of Neomedic, a leading neonatology and obstetrics hospital group in southern Poland, is completed.

Neomedic operates three hospitals with surrounding outpatient and primary care clinics. In addition, Neomedic operates ambulatory centres focused on obstetrics. The first hospital of Neomedic was established in 2001 in Kraków and it has since then shown strong organic growth. In 2018, 7,600 babies were born in its hospitals.

Neomedic was acquired for 70.5 MEUR and reported revenue of 27.1 MEUR for 2018. Its profitability will contribute positively to Medicover and the transaction value implies a high single digit EBITDA multiple, including synergies, which are expected to be realised within 12 months. The acquisition will be funded with current committed debt facilities and is expected to be accretive in 2019.The acquisition will be consolidated from mid-May.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations
+46 703033272
hanna.bjellquist@medicover.com

This information is information that Medicover AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 18.20 CEST on 10 May 2019.

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenue around €672 million and 20,970 employees. For more information, go to www.medicover.com